Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06346600
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-27
Brief Title:
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Sponsor:
Skyline Therapeutics
Organization:
Skyline Therapeutics
Study Overview
Official Title:
A Prospective Non-interventional Multicenter Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With Neovascular Wet Age-related Macular Degeneration nAMD
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Prospective Non-interventional Multicenter Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular Wet Age-related Macular Degeneration nAMD All subject who completed the parent clinical study NCT06213038 and NCT05986864 will undergo safety and efficacy assessments up to 5 years post study drug injection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None